Kradle Expands Feline Supplement Portfolio With Kradle Max Full-Spectrum Hemp Calming Tincture for Cats Kradle, a premium pet wellness brand known for its innovative and easy-to-use natural calming solutions for dogs and cats, today announced the launch of Kradle Max…
Keepit Receives 2025 Backup and Disaster Recovery Award from Cloud Computing Magazine Keepit, the only independent, cloud-native data protection and recovery provider, today announced that TMC, a global, integrated media company, has named Keepit platform as a 2025 Cloud Computing Backup…
The Global Mobile Medical Association Launches to Transform Community Healthcare with Unified Network The Global Mobile Medical Association (GMMA), the world’s first comprehensive network dedicated to advancing the mobile healthcare model, officially launched today. GMMA represents a turning point for…
Zoya Technologies Unveils ZoyeMed 3.0, an Edge-Native Autonomous AI Clinic, at WHX Dubai Zoya Technologies today unveiled ZoyeMed 3.0, an edge-native clinical terminal designed to deliver autonomous primary and acute care with humans in the loop. Presented at WHX Dubai 2026, the…
Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma Nuvation Bio Inc. a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced finalization of a protocol amendment to the…
GE HealthCare launches ReadyFix fleet management solution to help enhance operational efficiency and reliable patient care GE HealthCare today announced the United States launch of ReadyFix™, a remote fleet management solution designed to help healthcare systems support device uptime. ReadyFix will seamlessly…
Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR® Estrella Immunopharma, Inc. (Nasdaq: ESLA, ESLAW) a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases,…
VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS) VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the first participant has been…
Ethris and German Center for Infection Research (DZIF) Announce Strategic Collaboration to Develop mRNA-Based Vaccines Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (Deutsches Zentrum für Infektionsforschung, DZIF), today announced…
Tend Health and SafeHavenMD Announce Strategic Partnership to Expand Confidential Mental Health Care for Physicians Tend Health and SafeHavenMD today announced a strategic partnership to expand access to confidential, high-quality mental health care for physicians nationwide. As concerns around physician burnout, mental health,…